IHH Healthcare BhdXKLS:5225 +0.60%88 ROE % is 7.03% as of Mar. 2026, which is 36% above its 10-year median of 5.16. GuruFocus rates XKLS:5225 with a GF Score™ of 88/100 and a GF Value™ of RM8.10 (Fairly Valued). The stock has 7 warning signs investors should review. Among 623 Healthcare Providers & Services companies, IHH Healthcare Bhd ranks better than 53.13% on this metric.
The historical rank and industry rank for IHH Healthcare Bhd's ROE % or its related term are showing as below:
XKLS:5225'
s ROE % Range Over the Past 10 Years
Min: 1.19 Med: 5.16 Max: 10.68
Current: 6.99
During the past 13 years, IHH Healthcare Bhd's highest ROE % was 10.68%. The lowest was 1.19%. And the median was 5.16%.
XKLS:5225's ROE % is ranked better than 53.13% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.86
vs XKLS:5225: 6.99
IHH Healthcare Bhd (XKLS:5225) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
IHH Healthcare Bhd ROE % Related Terms
IHH Healthcare Bhd ROE % Historical Data
* Premium members only.
The historical data trend for IHH Healthcare Bhd's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's ROE % distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
IHH Healthcare Bhd (XKLS:5225) has a ROE % of 7.03% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on IHH Healthcare Bhd and its competitors. This is 36% above median its historical median of 5.16. Over the past decade, IHH Healthcare Bhd's ROE % has ranged from 1.19 to 10.68. According to the industry distribution chart, IHH Healthcare Bhd ranks #292 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is IHH Healthcare Bhd's ROE % too high?
IHH Healthcare Bhd's current ROE % of 7.03% is 36% above median its 10-year median of 5.16. Over the past 10 years, this metric has ranged from a low of 1.19 to a high of 10.68. The Healthcare Providers & Services industry median ROE % is 5.86. IHH Healthcare Bhd's value of 7.03% is 20% above this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #292 out of 623 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, IHH Healthcare Bhd has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #292 out of 623 companies for ROE %. This puts IHH Healthcare Bhd in the upper half of its industry. The industry median ROE % is 5.86. IHH Healthcare Bhd's value of 7.03% is 20% above this benchmark. Historically, IHH Healthcare Bhd's own ROE % has ranged from 1.19 to 10.68 over the past decade. While the company's 10-year median is 5.16 vs. the industry median of 5.86, IHH Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current ROE % of 7.03% is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on IHH Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current ROE % is 7.03%, which is 36% above median its own 10-year median of 5.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.10, compared to a current price of RM8.38 — trading 3.5% above its estimated fair value. The current ROE % is 7.03%, which is 36% above median its 10-year median of 5.16 and 20% above the Healthcare Providers & Services industry median of 5.86. IHH Healthcare Bhd's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current ROE % is 7.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued.
The current stock price of RM8.38 is trading 3.5% above its estimated GF Value™ of RM8.10.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
ROE %: 7.03% (36% above median its 10-year median of 5.16)
GF Value™: RM8.10 vs. price of RM8.38 (3.5% above fair value)
Industry Position: 20% above the Healthcare Providers & Services median (#292 of 623)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
88GF Score
Get the complete analysis for XKLS:5225
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
